Claritev Class A (CTEV) closed at $26.82 on November 13, 2026, down 0.3% from the previous close, on volume of 125,493 shares (30-day average 263,961).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 13, 2026 | Put with Delta Hedge | 16-Apr-27 25 P +46,500 Stock | 1,500 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
Claritev Earnings Call Signals Stronger Growth Ahead
TipRanks (Thu, 12-Nov 7:24 PM ET)
Analysts Are Bullish on Top Healthcare Stocks: Claritev (CTEV), Tyra Bioscience (TYRA)
TipRanks (Thu, 12-Nov 4:10 AM ET)
Claritev (CTEV) Receives a Buy from Guggenheim
TipRanks (Tue, 10-Nov 7:29 AM ET)
Canaccord Genuity Sticks to Their Buy Rating for Claritev (CTEV)
TipRanks (Tue, 10-Nov 7:29 AM ET)
TipRanks (Tue, 10-Nov 6:30 AM ET)
Claritev Corporation Reports Third Quarter 2026 Results
Globe Newswire (Mon, 9-Nov 6:00 AM ET)
Globe Newswire (Thu, 5-Nov 8:23 AM ET)
Globe Newswire (Thu, 29-Oct 10:30 AM ET)
Claritev Appoints Jennifer Main to its Board of Directors
Globe Newswire (Thu, 15-Oct 9:00 AM ET)
Claritev Corporation Announces Third Quarter 2026 Earnings Conference Call
Globe Newswire (Wed, 14-Oct 8:00 AM ET)
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Claritev Class A trades on the NYSE stock market under the symbol CTEV.
As of November 13, 2026, CTEV stock price declined to $26.82 with 125,493 million shares trading.
CTEV has a beta of 3.09, meaning it tends to be more sensitive to market movements. CTEV has a correlation of 0.07 to the broad based SPY ETF.
CTEV has a market cap of $457.95 million. This is considered a Small Cap stock.
Last quarter Claritev Class A reported $268 million in Revenue and -$3.64 earnings per share. This beat revenue expectation by $12 million and missed earnings estimates by -$4.27.
The top ETF exchange traded funds that CTEV belongs to (by Net Assets): VTI, IWM, VXF, IWN, FNDA.
CTEV has underperformed the market in the last year with a return of -39.3%, while the SPY ETF gained +13.4%. In the last 3 month period, CTEV fell short of the market, returning -36.5%, while SPY returned -2.8%. However, in the most recent 2 weeks CTEV has outperformed the stock market by returning +11.8%, while SPY returned -0.2%.
CTEV support price is $24.80 and resistance is $29.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTEV shares will trade within this expected range on the day.